11/25/2015 - 12:09pm

Despite pre-exposure prophylaxis pills’ efficacy in preventing HIV that’s transmitted sexually or through use of injected drugs, only one-in-three primary care physicians and nurses have heard of it. 

11/25/2015 - 10:37am

Novartis’ Fluad is a trivalent flu vaccine that contains the adjuvant MF59, an emulsion of squalene oil in water, and is aimed at improving immune response among patients 65 years of age and older. 

11/24/2015 - 11:18am

Mylan has introduced its generic of Jazz Pharmaceuticals’ schizophrenia treatment. 

11/23/2015 - 4:10pm

The FDA has approved Bristol-Myers Squibb’s Opdivo as a treatment for renal cell carcinoma in some patients. 

11/23/2015 - 4:01pm

Earlier this year, California and Oregon passed laws allowing pharmacists to prescribe birth control to patients. As the measure is set to roll out in the first half of 2016, the New York Times has reported on the growing trend of states allowing pharmacists to prescribe contraceptives, noting its potential impact on medically underserved populations. “I feel strongly that this is what’s best for women’s health in the 21st century, and I also feel it will have repercussions for decreasing poverty because one of the key things for women in poverty is unintended pregnancy,” Oregon Rep. Knute Buehler, the Republican who sponsored Oregon’s law, told NYT. (New York Times)

11/23/2015 - 3:49pm

Greenstone received final approval from the Food and Drug Administration for its generic Zyvox. 

11/23/2015 - 2:57pm

The new indication provides another option for the estimated 300,000 patients who will undergo hip replacements in a year. 

11/23/2015 - 2:01pm

Mylan has rolled out its MyFreshStart online tool for patients with hypertension taking Mavik in an effort to increase adherence among them. 

11/20/2015 - 4:03pm

In preparation for this launch, Mission has expanded its sales force and increased promotional efforts to reach more primary care and internal medicine healthcare providers.